Is HEXO Stock (TSX:HEXO) on the Verge of a Historic Boom?

HEXO stock and others like it have been beaten down. The company could surge upward or be an acquisition target as the market consolidates.

| More on:
edit Jars of marijuana

Image source: Getty Images

You’re reading a free article with opinions that may differ from The Motley Fool’s premium investing services. Become a Motley Fool member today to get instant access to our top analyst recommendations, in-depth research, investing resources, and more. Learn moresdf

Currently trading for just $1, Hexo (TSX:HEXO)(NYSE:HEXO) has had a rough year. Back in April, 2019, Hexo stock was worth nearly eight times as much. It’s a reflection of the struggles of the broader cannabis sector since the excitement of legalization wore off. 

However, the price is now so cheap that investors must consider if the company could be on the verge of a remarkable rebound. Here’s a closer look. 

Cannabis sector outlook

Legal cannabis is slowly but surely gaining strength across the country. Canadian spent $5.16 million on pot products every single day in February, according to data published by StatsCan. By the end of the year, sales could hit $1.9 billion. 

Sales have been spurred on by a number of factors. Firstly, cannabis retailers were deemed “essential businesses” in a number of provinces during the lockdown. With people confined to their homes, many spent more on alcohol and marijuana. Secondly, Cannabis 2.0 is now in full swing with edibles and beverages on shelves across the country. 

The price of a legal ounce of weed is still higher than the black market, but the gap is narrowing rapidly. There’s a lingering issue of corporate debt and oversupply hanging over the industry, but things are starting to look up.

HEXO stock valuation

Currently worth $1.35, Hexo stock is a fraction of its all-time high. However, underlying financials seem to be improving. Gross revenue jumped 30% to $30.9 million in the most recent quarter. Annualized, the company is on track to generate $120 million in sales. That means HEXO stock is trading at 4.6 times forward revenue per share. 

Plenty of restructuring and asset restructurings over the past few months have made the company a lot more efficient. It’s over the hurdle of financial struggles and could be able to sustain lower costs of production going forward. 

However, I believe HEXO stock’s value could ultimately be unlocked via acquisition. A larger rival with more cash could buy the company to further consolidate the market. The industry clearly seems to be heading for consolidation. That means investors who bought HEXO stock at its lowest months ago or are willing to step in today could be in for a premium buyout. 

HEXO’s diversified portfolio of THC-infused products and the upcoming release of THC-infused drinks could be an attractive addition for larger rivals. 

Foolish takeaway

Cannabis stocks have been on a wild ride. After exploding to ludicrous levels in 2018, stocks have been plummeting across the board for much of the past year. However, with sales picking up and prices stabilizing, the industry could finally be on the road to recovery. 

Meanwhile, HEXO stock and others like it have been beaten down. These established players could be acquisitions targets as the market consolidates. Investors should consider the underlying value HEXO has created over the years and isn’t being reflected in the HEXO stock price.  

Another leg upward could be on the horizon for this stock. 

This article represents the opinion of the writer, who may disagree with the “official” recommendation position of a Motley Fool premium service or advisor. We’re Motley! Questioning an investing thesis — even one of our own — helps us all think critically about investing and make decisions that help us become smarter, happier, and richer, so we sometimes publish articles that may not be in line with recommendations, rankings or other content.

Fool contributor Vishesh Raisinghani has no position in any of the stocks mentioned. The Motley Fool recommends HEXO. and HEXO.

More on Cannabis Stocks

Cannabis smoke
Cannabis Stocks

Canopy Growth Stock: Is Now a Good Time to Invest?

The road ahead is highly uncertain for Canopy Growth, as the stock is plagued with losses and seemingly unsurmountable industry…

Read more »

Cannabis grows at a commercial farm.
Cannabis Stocks

TLRY Stock: Should You Invest Now?

TLRY is a Canadian cannabis stock which is trading 91% below record highs. Let's see if you should own TLRY…

Read more »

Cannabis grows at a commercial farm.
Cannabis Stocks

Is Tilray Stock a Buy in February 2023?

Despite the volatile cannabis sector, Tilray could be a superb buy for long-term investors.

Read more »

Young woman sat at laptop by a window
Cannabis Stocks

Is SNDL Stock a Buy in February 2023?

SNDL is a beaten-down cannabis stock. While its revenue growth is exceptional, a weak balance sheet has driven stock prices…

Read more »

A cannabis plant grows.
Cannabis Stocks

TLRY Stock: Here’s What’s Coming in 2023

Tilray Inc. (TSX:TLRY) is geared up for big growth this decade and looks like one of the top cannabis stocks…

Read more »

A person holds a small glass jar of marijuana.
Cannabis Stocks

Canopy Growth Stock: Here’s What’s Coming in 2023

Canopy Growth stock has made a lot of new moves in the last few months, but where is the company…

Read more »

A cannabis plant grows.
Cannabis Stocks

Better Cannabis Buy: Canopy Growth Stock or Tilray?

Only two TSX weed stocks can deliver substantial returns in the highly anticipated growth of the global cannabis market.

Read more »

Medicinal research is conducted on cannabis.
Cannabis Stocks

Is Tilray Stock a Buy in January 2023?

Tilray stock has lost 50% of its value in the last 12 months, in line with its peers.

Read more »